Skip to content

Efficacy and safety of cream containing Centella asiatica extract for treatment of atopic dermatitis patients

Efficacy and safety of cream containing Centella Asiatica extract for treatment of mild to moderate atopic dermatitis patients

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20190806006
Enrollment
40
Registered
2019-08-06
Start date
2019-07-23
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin rash&#44

Interventions

Centella cream is an herbal preparation in the national list of essential drugs of Thailand and the list of herbal drugs of Chao Phya Abhaibhubejhr Hospital&#44
Prachinburi. The product was performed by Chao Phya Abhaibhubejhr Hospital Foundation and was GMP&#45
PIC/s certified. CA cream is comprised of 70% alcohol extract of CA (7% w/w) according to the national list of essential medicines. Centella cream is white in color. Usage: Participants will receive
appearance in white color and filled in the same package as Centella cream. Usage: Participants will receive the standard treatment and are acquired to apply Placebo cream on the rash twice daily for
Active Comparator Drug,Placebo Comparator Drug
Centella Cream,Placebo or base cream

Sponsors

Thammasat University
Lead Sponsor
Chao Phraya Abhaibhubejhr Hospital
Collaborator

Eligibility

Sex/Gender
All
Age
1 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1 Male and female 2 Age of 1&#45;17 years old 3 Patients have been diagnosed as atopic dermatitis by pediatric doctor 4 Atopic dermatitis patients with mild to moderate severity (SCORAD score < 40) 5 Onset not more than 6 months 6 Willing to participate in the trial

Exclusion criteria

Exclusion criteria: 1 History or presence of skin cancer of suspicious lesions 2 Participate in another study within the previous 4 weeks. 3 Allergy or sensitivity to CA or herbs in the family of Apiaceae 4 Applied any moisturizer on the skin lesions Discontinuation criteria 1 Skin lesions flare&#45;up in the volunteers (SCORAD score more than 40) 2 Secondary infection on&#45;top to the skin 3 The occurrence of any severe adverse event 4 Applied any moisturizer on the skin lesions 5 Loss follow up more than 1 visit&#44; or at the last week 6 Loss of follow up more than 1 appointment and at week 4 7 Do not desire to continue the trial

Design outcomes

Primary

MeasureTime frame
the severity of Atopic dermatitis 4 weeks SCORAD Score

Secondary

MeasureTime frame
Safety 4 weeks patient&#39;s interview&#44; Naranjo algorithm ,Quality of life 4 weeks IDQOL/CDLQI

Countries

Thailand

Contacts

Public ContactNutcha Tengtermwong

Chao Phraya Abhaibhubejhr

oillio.jck@gmail.com0959469192

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026